Stephen J. Aselage
2010
In 2010, Stephen J. Aselage earned a total compensation of $1.7M as Executive Vice President & Chief Business Officer at BioMarin Pharmaceutical, a 24% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $158,738 |
|---|---|
| Option Awards | $943,320 |
| Salary | $364,731 |
| Stock Awards | $240,912 |
| Other | $7,823 |
| Total | $1,715,524 |
Aselage received $943.3K in option awards, accounting for 55% of the total pay in 2010.
Aselage also received $158.7K in non-equity incentive plan, $364.7K in salary, $240.9K in stock awards and $7.8K in other compensation.
Rankings
In 2010, Stephen J. Aselage's compensation ranked 3,525th out of 10,439 executives tracked by ExecPay. In other words, Aselage earned more than 66.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,525 out of 10,439 | 66th |
Division Manufacturing | 1,226 out of 3,837 | 68th |
Major group Chemicals And Allied Products | 240 out of 925 | 74th |
Industry group Drugs | 134 out of 684 | 80th |
Industry Pharmaceutical Preparations | 102 out of 480 | 79th |
Source: SEC filing on March 23, 2012.
Aselage's colleagues
We found four more compensation records of executives who worked with Stephen J. Aselage at BioMarin Pharmaceutical in 2010.